Regenerative Medical Technology Group annual debt-to-assets ratio
2018
2019
2020
2022
2023
2024
2025
Regenerative Medical Technology Group Debt-to-Assets Ratio Growth & History (RMTG)
Regenerative Medical Technology Group's debt-to-assets ratio was 0.62 for fiscal 2025.
View full Regenerative Medical Technology Group company overviewRegenerative Medical Technology Group annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.62 | 0.54 | +642.41% |
| 2024 | 2024-12-31 | 0.08 | 0.08 | +8738.66% |
| 2023 | 2023-12-31 | 0.00 | −0.00 | −77.57% |
| 2022 | 2022-12-31 | 0.00 | — | — |
| 2020 | 2020-12-31 | 0.67 | −47.66 | −98.60% |
| 2019 | 2019-12-31 | 48.33 | 24.86 | +105.94% |
| 2018 | 2018-12-31 | 23.47 | — | — |
Regenerative Medical Technology Group quarterly debt-to-assets ratio
Q4.18
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.48 | 0.41 | +577.72% |
| Q1 2026 | 2026-03-31 | 0.13 | 0.05 | +54.69% |
| Q4 2025 | 2025-12-31 | 0.62 | 0.54 | +642.41% |
| Q3 2025 | 2025-09-30 | 0.13 | — | — |
| Q2 2025 | 2025-06-30 | 0.07 | 0.04 | +98.99% |
| Q1 2025 | 2025-03-31 | 0.08 | 0.04 | +103.17% |
| Q4 2024 | 2024-12-31 | 0.08 | 0.08 | +8738.66% |
| Q2 2024 | 2024-06-30 | 0.04 | 0.03 | +1334.97% |
| Q1 2024 | 2024-03-31 | 0.04 | 0.04 | +1141.63% |
| Q4 2023 | 2023-12-31 | 0.00 | −0.00 | −77.57% |
| Q3 2023 | 2023-09-30 | 0.00 | −0.00 | −35.51% |
| Q2 2023 | 2023-06-30 | 0.00 | −0.00 | −57.54% |
| Q1 2023 | 2023-03-31 | 0.00 | −0.00 | −47.59% |
| Q4 2022 | 2022-12-31 | 0.00 | — | — |
| Q3 2022 | 2022-09-30 | 0.01 | — | — |
| Q2 2022 | 2022-06-30 | 0.01 | −0.01 | −57.13% |
| Q1 2022 | 2022-03-31 | 0.01 | −0.15 | −95.94% |
| Q2 2021 | 2021-06-30 | 0.01 | −31.48 | −99.96% |
| Q1 2021 | 2021-03-31 | 0.15 | −116.28 | −99.87% |
| Q4 2020 | 2020-12-31 | 0.67 | −47.66 | −98.60% |
| Q3 2020 | 2020-09-30 | 10.43 | — | — |
| Q2 2020 | 2020-06-30 | 31.50 | — | — |
| Q1 2020 | 2020-03-31 | 116.44 | — | — |
| Q4 2019 | 2019-12-31 | 48.33 | 24.86 | +105.94% |
| Q4 2018 | 2018-12-31 | 23.47 | — | — |
Regenerative Medical Technology Group debt-to-assets ratio trends
Over the last five fiscal years, Regenerative Medical Technology Group's debt-to-assets ratio decreased from 0.67 to 0.62, a change of −0.06. The latest reported quarter, Q2 2026, shows 0.48.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Regenerative Medical Technology Group source filings ↗